Under the Biden administration's proposal, only those who are considered obese — someone who has a body mass index of 30 or higher — would qualify for...
The Trump administration on Friday rejected a Biden administration plan that would have required Medicare and Medicaid to cover obesity drugs and expanded access for millions of people.
President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program.
The Trump administration today rejected a Biden administration plan that would have required Medicare and Medicaid to cover obesity drugs and expanded access for millions of people.
The Centers for Medicare and Medicaid Services (CMS) announced Friday it will not be finalizing a rule proposed by the Biden administration that would have allowed Medicare and Medicaid beneficiaries access to anti-obesity drugs such as the highly in-demand GLP-1 medications.
President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the government-funded Medicare program
Trump administration nixed a Biden-era plan this week that would have lifted the ban on coverage of obesity medicines by Medicare and expanded access in Medicaid.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
